To help make this website function we have placed cookies on your computer. You can see what cookies we have set at any time.
We'll assume that you're OK to continue using this site.

Don't show me this message again.

Generics bulletin

You focus on generics and biosimilars

So do we ...

Let us bring you the news that matters to your industry.

Don't waste time sifting through pharma noise. Generics bulletin delivers all the information you need to make better decisions faster.

Join thousands of subscribers from companies in nearly 60 countries who are already benefitting from commercial intelligence about business opportunities in the global generic medicines and biosimilars markets.

Accurate and reliable news reports reveal the strategies of the world's leading generics companies and analyse their business performance, plans and portfolios.

And a searchable archive offers an invaluable resource for researching market opportunities, benchmarking competitive strengths, evaluating regulatory changes and assessing product developments.

Take out your own subscription today


 Individual subscriptions

An annual subscription comprises:

  • 46 Generics bulletin online editions – published on Fridays
  • a searchable archive of more than 100 back editions dating back over five years
  • 46 optional hard-copy print editions, delivered by airmail.

Choice of formats

Generics bulletin can be accessed from:

  • Desktop and laptop computers AND
  • Apple and Android tablets and smartphones.



Multiple subscriptions

Discounts are available for multi-user subscriptions for colleagues. See subscription rates.


Corporate subscriptions

Corporate Subscriptions provide location-, country- or company-wide access. Contact for further details.

Subscribe to OTC bulletin

OTC bulletin is the sister publication of Generics bulletin. Established for more than 20 years, OTC bulletin is the leading Europe-based newsletter for the global consumer healthcare industry, providing unrivalled news coverage and strategic insights. Special rates are available for subscribers to both publications. See subscription rates.

Generics bulletin trial link